Rheintal, 31.08.2020
How the preferential approval of COVID-19-relevant medical devices and in vitro diagnostics in Europe is possible during the COVID-19 pandemic is explained by Dr Jens Hain, Business and Clinical Development Director at TRIGA-S, in a lecture at the N-Tec Talks in Dornbirn. The company has many years of experience in all areas of clinical and technical testing and focuses on clinical studies for in vitro diagnostics. Dr Hain is one of a number of speakers who will share their knowledge free of charge in Dornbirn at the W3+ Rhine Valley 2020 trade fair on 23 and 24 September 2020. Find out more about the complete N-Tec Talks lecture programme.
